A Randomized Phase III Trial to Assess Response Adapted Therapy Using FDG-PET Imaging in Patients With Newly Diagnosed, Advanced Hodgkin Lymphoma.
Latest Information Update: 18 Sep 2021
At a glance
- Drugs Bleomycin; Cyclophosphamide; Dacarbazine; Doxorubicin; Etoposide; Prednisolone; Procarbazine; Vinblastine; Vincristine
- Indications Hodgkin's disease
- Focus Therapeutic Use
- Acronyms RATHL
Most Recent Events
- 28 Apr 2021 Biomarkers information updated
- 03 Mar 2012 Additional lead trial centres identified as reported by EudraCT.
- 03 Mar 2012 Additional trial locations (Australia, Denmark, Ireland, Italy, New Zealand, Norway, Sweden) identified as reported by EudraCT.